Safety and efficacy of infliximab biosimilar (Remsima (c)) in Crohn's disease patients in clinical practice: results after 6 months of treatment
JOURNAL OF CROHNS & COLITIS(2016)
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要
JOURNAL OF CROHNS & COLITIS(2016)